Adèle Delamarre

587 total citations
14 papers, 178 citations indexed

About

Adèle Delamarre is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Adèle Delamarre has authored 14 papers receiving a total of 178 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Epidemiology, 12 papers in Hepatology and 1 paper in Surgery. Recurrent topics in Adèle Delamarre's work include Liver Disease Diagnosis and Treatment (14 papers), Liver Disease and Transplantation (7 papers) and Hepatocellular Carcinoma Treatment and Prognosis (6 papers). Adèle Delamarre is often cited by papers focused on Liver Disease Diagnosis and Treatment (14 papers), Liver Disease and Transplantation (7 papers) and Hepatocellular Carcinoma Treatment and Prognosis (6 papers). Adèle Delamarre collaborates with scholars based in France, Hong Kong and China. Adèle Delamarre's co-authors include Victor de Lédinghen, Marie Irlès‐Depé, Marine Roux, Charlotte Costentin, Vincent Wai‐Sun Wong, Jérôme Boursier, Clémence M. Canivet, Isabelle Fouchard, F. Oberti and Nathalie Stürm and has published in prestigious journals such as SHILAP Revista de lepidopterología, Hepatology and Journal of Hepatology.

In The Last Decade

Adèle Delamarre

14 papers receiving 177 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Adèle Delamarre France	7	165	121	43	30	19	14	178
Zhen Yu Wong United Kingdom	8	108 0.7×	58 0.5×	40 0.9×	21 0.7×	26 1.4×	31	158
Sui‐Weng Wong Malaysia	6	133 0.8×	69 0.6×	43 1.0×	28 0.9×	23 1.2×	6	170
Masato Yoneda Japan	3	197 1.2×	111 0.9×	72 1.7×	24 0.8×	37 1.9×	4	205
Dominique Thabut France	4	137 0.8×	115 1.0×	21 0.5×	32 1.1×	11 0.6×	6	149
Barbara Dauvois France	4	245 1.5×	166 1.4×	39 0.9×	98 3.3×	22 1.2×	5	273
Yuly P. Mendoza Switzerland	8	210 1.3×	176 1.5×	35 0.8×	19 0.6×	79 4.2×	15	241
Douglas Chee Singapore	7	97 0.6×	63 0.5×	26 0.6×	11 0.4×	20 1.1×	14	142
Harris Siddiqi United States	8	95 0.6×	45 0.4×	30 0.7×	10 0.3×	26 1.4×	17	122
Anneli Andersson United Kingdom	4	124 0.8×	65 0.5×	43 1.0×	6 0.2×	15 0.8×	7	144
Anita Arslanow Germany	6	248 1.5×	165 1.4×	80 1.9×	28 0.9×	21 1.1×	16	279

Countries citing papers authored by Adèle Delamarre

Since Specialization

Citations

This map shows the geographic impact of Adèle Delamarre's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adèle Delamarre with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adèle Delamarre more than expected).

Fields of papers citing papers by Adèle Delamarre

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adèle Delamarre. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adèle Delamarre. The network helps show where Adèle Delamarre may publish in the future.

Co-authorship network of co-authors of Adèle Delamarre

This figure shows the co-authorship network connecting the top 25 collaborators of Adèle Delamarre. A scholar is included among the top collaborators of Adèle Delamarre based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adèle Delamarre. Adèle Delamarre is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Mouillot, Thomas, Luisa Vonghia, Charlotte Costentin, et al.. (2025). Non-invasive tests for fibrotic MASH for reducing screen failure in therapeutic trials. JHEP Reports. 7(4). 101351–101351. 4 indexed citations

Foucher, Juliette, et al.. (2025). Hepatoscope 2DTE's image-based quality index enhances applicability and repeatability of liver stiffness measurement. Clinics and Research in Hepatology and Gastroenterology. 49(2). 102532–102532. 1 indexed citations

Besson, Adrien, et al.. (2024). Quantitative ultrasound for steatosis assessment using Hepatoscope®: Confounding technical factors. SHILAP Revista de lepidopterología. 2(2). 100069–100069. 1 indexed citations

Lin, Huapeng, Jimmy Che‐To Lai, Grace Lai–Hung Wong, et al.. (2023). Risk and predictors of hepatic decompensation in grey zone patients by the Baveno VII criteria: A competing risk analysis. Alimentary Pharmacology & Therapeutics. 58(9). 920–928. 11 indexed citations

Delamarre, Adèle, et al.. (2023). Conduite à tenir devant une élévation chronique du taux des transaminases. La Revue de Médecine Interne. 44(10). 555–560. 1 indexed citations

Pons, Mònica, Jesús Rivera‐Esteban, Mang Ma, et al.. (2023). Point-of-Care Noninvasive Prediction of Liver-Related Events in Patients With Nonalcoholic Fatty Liver Disease. Clinical Gastroenterology and Hepatology. 22(8). 1637–1645.e9. 27 indexed citations

Li, Jie, Adèle Delamarre, Vincent Wai‐Sun Wong, & Victor de Lédinghen. (2023). Diagnosis and assessment of disease severity in patients with nonalcoholic fatty liver disease. United European Gastroenterology Journal. 12(2). 219–225. 6 indexed citations

Lin, Huapeng, Guanlin Li, Adèle Delamarre, et al.. (2023). A Liver Stiffness–Based Etiology-Independent Machine Learning Algorithm to Predict Hepatocellular Carcinoma. Clinical Gastroenterology and Hepatology. 22(3). 602–610.e7. 12 indexed citations

Delamarre, Adèle, et al.. (2023). LIVERFASt GP+, first-line screening tool in at-risk MAFLD patients outperforms the standard-of-care (SOC) FIB-4. Journal of Hepatology. 78. S674–S675. 1 indexed citations

10.

Pennisi, Grazia, Marco Enea, Manuel Romero‐Gómez, et al.. (2023). Risk of liver-related events in metabolic dysfunction–associated steatohepatitis (MASH) patients with fibrosis: A comparative analysis of various risk stratification criteria. Hepatology. 79(4). 912–925. 8 indexed citations

11.

Boursier, Jérôme, Clémence M. Canivet, Charlotte Costentin, et al.. (2022). Impact of Type 2 Diabetes on the Accuracy of Noninvasive Tests of Liver Fibrosis With Resulting Clinical Implications. Clinical Gastroenterology and Hepatology. 21(5). 1243–1251.e12. 51 indexed citations

12.

Canivet, Clémence M., Charlotte Costentin, Katharine M. Irvine, et al.. (2022). Validation of the new 2021 EASL algorithm for the noninvasive diagnosis of advanced fibrosis in NAFLD. Hepatology. 77(3). 920–930. 25 indexed citations

13.

Canivet, Clémence M., Adrien Lannes, Charlotte Costentin, et al.. (2022). Validation of the new 2021 EASL algorithm for the non-invasive diagnosis of advanced liver fibrosis in non-alcoholic fatty liver disease. Journal of Hepatology. 77. S74–S75. 3 indexed citations

14.

Dutartre, Dan, Jean‐Baptiste Hiriart, Marie Irlès‐Depé, et al.. (2021). Long‐term prognosis of patients with alcohol‐related liver disease or non‐alcoholic fatty liver disease according to metabolic syndrome or alcohol use. Liver International. 42(2). 350–362. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact